HEXAGON — Hexagon Nutrition Balance Sheet
0.000.00%
- IN₹7.54bn
- IN₹7.57bn
- IN₹3.83bn
Annual balance sheet for Hexagon Nutrition, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 509 | 523 | 429 | 540 | 576 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 726 | 802 | 541 | 649 | 817 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,922 | 2,240 | 1,787 | 1,836 | 2,414 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 616 | 604 | 673 | 675 | 659 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,566 | 2,889 | 2,505 | 2,614 | 3,184 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 877 | 1,163 | 600 | 527 | 713 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 969 | 1,258 | 747 | 672 | 851 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 1,597 | 1,631 | 1,759 | 1,942 | 2,333 |
| Total Liabilities & Shareholders' Equity | 2,566 | 2,889 | 2,505 | 2,614 | 3,184 |
| Total Common Shares Outstanding |